FAQ

CR002

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2015
0120032015

Related topics

Related topics

1 relation

Broader (1)

Monoclonal Antibodies

Related mentions per year

Related mentions per year

1950-2018
1960198020002020
CR002
Monoclonal Antibodies

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Safety and efficacy of a novel Prunus domestica extract (Sitoprin, CR002) on testosterone-induced benign prostatic hyperplasia (BPH) in male Wistar rats.
The efficacy of a novel Prunus domestica bark extract (Sitoprin, CR002) was investigated on testosterone propionate (TP)-induced… (More)
Is this relevant?
2008
2008
A phase I study of CR002, a fully-human monoclonal antibody against platelet-derived growth factor-D.
OBJECTIVE To investigate the safety, pharmacokinetics (PK), binding activity and immunogenicity of CR002, a human monoclonal… (More)
Is this relevant?
2007
2007
PDGF-D inhibition by CR002 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis.
BACKGROUND Arresting or regressing kidney scarring is of major clinical relevance. Platelet-derived growth factor D (PDGF-D) is… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2006
2006
Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis.
Glomerular mesangial cell proliferation and/or matrix accumulation characterizes many progressive renal diseases. PDGF-D was… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
2003
2003
A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis.
PDGF-B is of central importance in mesangioproliferative diseases. PDGF-D, a new PDGF isoform, like PDGF-B, signals through the… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?